Guru Ownership Trend
Guru Analysis for Xenon Pharmaceuticals Inc. (XENE)
Xenon Pharmaceuticals Inc. (XENE), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q4 2025, a total of 2 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $22.4 M.
Top institutional holders include Paul Tudor Jones and Louis Moore Bacon.
Institutional sentiment is currently Bullish. This is evidenced by a $7.73 M net inflow during the quarter.
Recent activity highlights Paul Tudor Jones who increased their stake by 230.6%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q4 2025)
Guru Consensus (Q4 2025)
FAQs for Xenon Pharmaceuticals Inc. (XENE)
Major holders include Paul Tudor Jones ($11.38 M), Louis Moore Bacon ($6.27 M). According to the latest reported data, 2 tracked investment managers collectively hold approximately 394,002 shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $7.73 M, with 1 managers increasing positions and 1 managers reducing holdings.
During the most recent reporting period, 0 managers trimmed their positions, while 1 fully exited XENE. The total reported sell value was $208,780.
Yes, 0 managers opened new positions in XENE, and 1 increased their existing holdings. The total reported buy value was $7.94 M.